Brief: AFT Pharmaceuticals Says Scomara Tentative Approval By US FDA
21/07/2026 02:42
BRIEF-AFT Pharmaceuticals Says Scomara Tentative Approval By US FDA July 21 (Reuters) - AFT Pharmaceuticals Ltd AFT.NZ:
SCOMARA TENTATIVE APPROVAL BY US FDA
Further company coverage: AFT.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV